RxDoctor Payments Data

Richard Wilkerson, MD

Emergency Medicine · Baltimore, MDNPI 1578735551

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $161 of the $233 with a category attached, or 69.1%. 3 manufacturers reported payments, led by Novartis at 52.8% of the total. Reporting peaked in 2019 at $123 and has fallen 88.1% since, to $15 in 2023.

$233in general payments, 2019–2025

Across 4 payments — averaging $58.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$123
  • Astellas Pharma US Inc$72
  • Vapotherm Inc$38
$1,275,314in research payments, 2019–2025

Across 90 payments — averaging $14,170 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$387K
  • Greiner Bio-one North America, Inc.$366K
  • BD$132K
  • Pfizer$129K
  • Vapotherm Inc$124K
  • Eli Lilly$59K
  • plus $79K from 4 others

What the payments were for

  • Food & beverage$16169%
  • Education$7231%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis1$123
Astellas Pharma US Inc1$72
Vapotherm Inc2$38

How this compares

$233 in reported general payments places this provider in the 85th percentile of 925 emergency medicine providers in Maryland.

See all emergency medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$15,091
Medicare patients
89
Services billed
151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other emergency medicine in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →